Atlas Trials

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Clinical trial NCT06969170 · RECRUITING

Trial details

NCT number
NCT06969170
Sponsor
Claudio N Soares
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Generalized Anxiety Disorder (GAD)
Start date
2025-05-16
Primary completion
2027-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.